Company

PanOptica Inc.

PanOptica develops antibody therapies for ophthalmic conditions.

About

PanOptica is a biotechnology company based in Bernardsville, US, focused on developing therapies for eye conditions. Founded in 2009, the company is led by CEO David Bingaman and was founded by Paul Chaney. Its Series B funding in April 2019 raised USD 10.47 million from SV Health Investors and Third Rock Ventures.

6Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in